Monoclonal Antibodies and Vaccines

Lydia Buckmaster
Mind Map by , created almost 6 years ago

Undergraduate Biotechnology in Animal Physiology Mind Map on Monoclonal Antibodies and Vaccines, created by Lydia Buckmaster on 01/18/2014.

Lydia Buckmaster
Created by Lydia Buckmaster almost 6 years ago
Lydia Buckmaster
Introduction to DNA
Lydia Buckmaster
Logic Pro X Practice Exam
Chris Redding
Sociology: Crime and Deviance Flash cards
Beth Morley
AQA Sociology A Level: Ethnic Differences in Achievement - Internal Factors 1
Rhiann .
Advanced Concepts in Stem Cell Biology
Lydia Buckmaster
Basic Concepts in Stem Cell Biology
Lydia Buckmaster
Lydia Buckmaster
Introduction to DNA 2
Lydia Buckmaster
Chromatin and Epigenetics
Lydia Buckmaster
Monoclonal Antibodies and Vaccines
1 Immunoglobulins (antibodies)
1.1 Y-shaped proteins
1.1.1 Locate and neutralise foreign particles in the body
1.2 Each specific to a unique part of a foreign object
1.2.1 Antigens
1.3 Conserved and variable regions
1.3.1 Each tip contains a paratope Specific for a particular epitope on an antigen Key Allows precise binding of antigens and antibodies, which tags foreign particles for attack by the immune system Lock
1.4 Formed from two heavy polypeptide chains and two light polypeptide chains, with two variable sites for antigen recognition
2 Polyclonal antibodies
2.1 Derived from many B cell lines and were first used to treat infectious diseases
2.1.1 Tetanus and diphtheria
2.2 Use limited due to low reproducibility and consistency and variable toxicity
3 Monoclonal Antibodies
3.1 Derived from identical B cells that are clones of a parent cell
3.1.1 Monospecific for a certain antigen
3.1.2 Can be produced in bulk to identify, bind to or eliminate a target substance in the blood Used massively in biochemistry and medicine
3.2 Currently 21 human therapeutic monoclonal antibodies, with over 100 more in clinical trials
3.3 Produced by injecting a mouse with an antigen, causing its immune cells to produce the complementary antibody, immunising the animal
3.3.1 Immune cells that produce the antibody are isolated, extracted and fused with tumour cells, making hybridomas Unfused cells die as they lack the HGPRT enzyme to survive in a HAT medium Hybridomas are screened for antibody production and then are cloned, making many cells which all produce the desired antibody
3.4 Used in the treatment of cancer, autoimmune diseases, eye disorders and cardiovascular systems
4 Chimeric Antibodies
4.1 Fusion Antibodies
4.2 Produced from the recombination of genes coding for antibodies
4.2.1 An all-rodent antibody the would not function in a human can be fused with an all-human antibody Creates a chimeric humanised antibody Originally produced in the mouse but is fully functional in humans, with around 90% human sequence
4.3 Less immunogenic
4.3.1 Less able to produce an immune response
4.4 Examples
4.4.1 Rituxan Used for treating Non-Hodgkins lymphoma
4.4.2 Remicale Used for treating rheumatoid arthritis and Crohn's disease
4.5 Human antibody libraries
4.5.1 Created by obtaining immune serum from patients Or by mutagenesis with PCR techniques that are more prone to mutations Increases the variability of the antigens
5 Vaccines
5.1 Biological preparations that boost the immune system to protect agains pathogens
5.2 Types
5.2.1 Live attenuated Pathogen grown in culture, usually as a less virulent form
5.2.2 Killed/inactive Pathogen is chemically inactivated Inactivated by things such as formaldehyde
5.2.3 Subunit Use antigenic parts of the pathogen, which can still illicit a response
5.3 Under development
5.3.1 Recombinant adenoviral vectors Efficient delivery system into human cells Viruses genetically altered to carry foreign proteins, which elicit an immune response By combining the physiology of one pathogen and the DNA of another, vaccinations can be carried out for diseases with complex infection methods
5.3.2 Recombinant BCG vaccines Made up of genes of various strains of pathogen Very efficient B and T cell responses
5.3.3 DNA vaccines Plasmid DNA (antigenic transgenes) are injected with an immunomodulator to increase their transcription and efficacy
5.4 Adjuvant
5.4.1 Added to a vaccine to boost the resulting immune response to the antigen
5.4.2 Act in various ways As an antigen store - releases slowly to maximise response As an irritant - causes the body to recruit and amplify response Activates T cells and lymphocytes
5.4.3 Many different types, from inorganic compounds such as aluminium hydroxide to emulsifying oils
5.4.4 Some side effects include inflammation
5.5 Toll-like receptors
5.5.1 Key role in the immune response
5.5.2 Detect foreign particles and elicit a response
5.5.3 Receptors in dendritic cells Provide early detection of things such as ssRNA (viral particles) and LPS (bacterial membrane proteins) Understanding of this mechanism allows specific targeting of parts of the immune response and allows for a more versatile vaccine design Adjuvants could be added to the vaccine to activate certain TLRs
6 Viruses mutate and evolve, so vaccinations often need to protect from multiple strains of the same infection
6.1 The Avian Influenza virus crossed the species barrier in 1918, infecting humans
6.1.1 H1N1 Main antigens are referred to in the name Haemaglutinin (HA) Neuraminidase (NA)
6.1.2 This virus has mutated many times since, changing the gene sequence which codes for the antigens Given rise to new strains H2N2 H3N2 Vaccination must therefore protect against all of these strains, as all of them still exist

Media attachments